Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies

10.3390/biom12091261

Saved in:
Bibliographic Details
Main Authors: Mustafa, Nurulhuda, Azaman, Muhamad Irfan, Ng, Giselle GK, Chng, Wee Joo
Other Authors: CANCER SCIENCE INSTITUTE OF SINGAPORE
Format: Review
Language:English
Published: MDPI 2022
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/234467
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Language: English
id sg-nus-scholar.10635-234467
record_format dspace
spelling sg-nus-scholar.10635-2344672024-04-18T01:03:45Z Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies Mustafa, Nurulhuda Azaman, Muhamad Irfan Ng, Giselle GK Chng, Wee Joo CANCER SCIENCE INSTITUTE OF SINGAPORE MEDICINE Science & Technology Life Sciences & Biomedicine Biochemistry & Molecular Biology CD38 immunotherapy blood malignancies daratumumab drug combination extracellular vesicles miRNA CHRONIC LYMPHOCYTIC-LEUKEMIA MULTIPLE-MYELOMA CELLS T-CELL RETINOIC ACID OPEN-LABEL REGULATORY CELLS MUTATION STATUS FLOW-CYTOMETRY B-CLL EXPRESSION 10.3390/biom12091261 BIOMOLECULES 12 9 2022-11-14T03:34:28Z 2022-11-14T03:34:28Z 2022-09-01 2022-11-13T14:55:30Z Review Mustafa, Nurulhuda, Azaman, Muhamad Irfan, Ng, Giselle GK, Chng, Wee Joo (2022-09-01). Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies. BIOMOLECULES 12 (9). ScholarBank@NUS Repository. https://doi.org/10.3390/biom12091261 2218-273X https://scholarbank.nus.edu.sg/handle/10635/234467 en MDPI Elements
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
language English
topic Science & Technology
Life Sciences & Biomedicine
Biochemistry & Molecular Biology
CD38
immunotherapy
blood malignancies
daratumumab
drug combination
extracellular vesicles
miRNA
CHRONIC LYMPHOCYTIC-LEUKEMIA
MULTIPLE-MYELOMA CELLS
T-CELL
RETINOIC ACID
OPEN-LABEL
REGULATORY CELLS
MUTATION STATUS
FLOW-CYTOMETRY
B-CLL
EXPRESSION
spellingShingle Science & Technology
Life Sciences & Biomedicine
Biochemistry & Molecular Biology
CD38
immunotherapy
blood malignancies
daratumumab
drug combination
extracellular vesicles
miRNA
CHRONIC LYMPHOCYTIC-LEUKEMIA
MULTIPLE-MYELOMA CELLS
T-CELL
RETINOIC ACID
OPEN-LABEL
REGULATORY CELLS
MUTATION STATUS
FLOW-CYTOMETRY
B-CLL
EXPRESSION
Mustafa, Nurulhuda
Azaman, Muhamad Irfan
Ng, Giselle GK
Chng, Wee Joo
Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies
description 10.3390/biom12091261
author2 CANCER SCIENCE INSTITUTE OF SINGAPORE
author_facet CANCER SCIENCE INSTITUTE OF SINGAPORE
Mustafa, Nurulhuda
Azaman, Muhamad Irfan
Ng, Giselle GK
Chng, Wee Joo
format Review
author Mustafa, Nurulhuda
Azaman, Muhamad Irfan
Ng, Giselle GK
Chng, Wee Joo
author_sort Mustafa, Nurulhuda
title Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies
title_short Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies
title_full Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies
title_fullStr Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies
title_full_unstemmed Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies
title_sort molecular determinants underlying the anti-cancer efficacy of cd38 monoclonal antibodies in hematological malignancies
publisher MDPI
publishDate 2022
url https://scholarbank.nus.edu.sg/handle/10635/234467
_version_ 1800915702570287104